VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 131 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $178 | -29.6% | 23,025 | +4.1% | 0.00% | – |
| Q2 2023 | $253 | +178.0% | 22,126 | +86.5% | 0.00% | – |
| Q1 2023 | $91 | +85.7% | 11,866 | +46.7% | 0.00% | – |
| Q4 2022 | $49 | -99.9% | 8,091 | -21.3% | 0.00% | – |
| Q3 2022 | $60,000 | 0.0% | 10,283 | 0.0% | 0.00% | – |
| Q2 2022 | $60,000 | -55.2% | 10,283 | -41.8% | 0.00% | – |
| Q1 2022 | $134,000 | +605.3% | 17,678 | +144.7% | 0.00% | – |
| Q4 2021 | $19,000 | +26.7% | 7,223 | +21.0% | 0.00% | – |
| Q3 2021 | $15,000 | -58.3% | 5,970 | -33.2% | 0.00% | – |
| Q2 2021 | $36,000 | – | 8,940 | +4922.5% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 178 | -98.5% | 0.00% | – |
| Q4 2020 | $86,000 | +473.3% | 12,102 | +1225.5% | 0.00% | – |
| Q3 2019 | $15,000 | -96.9% | 913 | -96.4% | 0.00% | -100.0% |
| Q1 2018 | $482,000 | +44.3% | 25,658 | +27.2% | 0.00% | 0.0% |
| Q4 2017 | $334,000 | – | 20,179 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
| ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
| Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
| BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
| Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
| GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
| Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
| HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
| Birchview Capital, LP | 33,000 | $310,000 | 0.29% |